Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
HC Wainwright

HC Wainwright Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at HC Wainwright. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from HC Wainwright's equity research team. MarketBeat is not affiliated with or endorsed by HC Wainwright.

Average Return
00.00% 12-Month ROI
Total Ratings
2,089 Last 12 Months
Buy Ratings
1,919 Last 12 Months
Sell Ratings
12 Last 12 Months
Companies Covered
638 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
0 Results
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Achieve Life Sciences, Inc. stock logo
ACHV
Achieve Life Sciences
$6.49
-0.2%
10/23/2026Reiterated RatingBuyView details for HC Wainwright rating of Achieve Life Sciences (NASDAQ:ACHV) on 10/23/2026
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$6.93
-7.0%
10/23/2026Reiterated RatingBuy ➝ NeutralView details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 10/23/2026
Integra Resources Corp. stock logo
ITRG
Integra Resources
$2.21
-2.2%
10/23/2026Lower Price Target$6.75 ➝ $6.50BuyView details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 10/23/2026
Biodesix, Inc. stock logo
BDSX
Biodesix
$21.18
-11.5%
10/22/2026Reiterated RatingBuyView details for HC Wainwright rating of Biodesix (NASDAQ:BDSX) on 10/22/2026
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
$5.39
-5.9%
10/22/2026Reiterated RatingBuyView details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 10/22/2026
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$42.93
-2.2%
10/22/2026Reiterated RatingBuyView details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 10/22/2026
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$10.80
-8.9%
10/22/2026Reiterated Rating$36.00BuyView details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 10/22/2026
Parabilis Medicines, Inc. stock logo
PBLS
Parabilis Medicines
$24.44
-9.2%
10/22/2026Initiated Coverage$40.00BuyView details for HC Wainwright rating of Parabilis Medicines (NASDAQ:PBLS) on 10/22/2026
GE Aerospace stock logo
GE
GE Aerospace
$285.76
-2.7%
10/21/2026 Set Price Target$375.00View details for HC Wainwright rating of GE Aerospace (NYSE:GE) on 10/21/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$0.97
+3.4%
10/21/2026Reiterated Rating$12.00BuyView details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 10/21/2026
AgomAb Therapeutics NV stock logo
AGMB
AgomAb Therapeutics
$9.05
-2.3%
10/21/2026Reiterated RatingBuyView details for HC Wainwright rating of AgomAb Therapeutics (NASDAQ:AGMB) on 10/21/2026
Oculis Holding AG stock logo
OCS
Oculis
$7.90
-2.3%
10/21/2026Reiterated Rating$39.00BuyView details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 10/21/2026
Centrus Energy Corp. stock logo
LEU
Centrus Energy
$102.38
-1.7%
10/21/2026Reiterated Rating$300.00BuyView details for HC Wainwright rating of Centrus Energy (NYSE:LEU) on 10/21/2026
Spyglass Pharma, Inc. stock logo
SGP
Spyglass Pharma
$28.48
+0.9%
10/21/2026Reiterated Rating$37.00BuyView details for HC Wainwright rating of Spyglass Pharma (NASDAQ:SGP) on 10/21/2026
Silence Therapeutics PLC Sponsored ADR stock logo
SLN
Silence Therapeutics
$19.67
+0.1%
10/21/2026Downgrade$75.00 ➝ $20.00Buy ➝ NeutralView details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 10/21/2026
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
$6.50
-1.7%
10/20/2026Reiterated RatingBuyView details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 10/20/2026
Absci Corporation stock logo
ABSI
Absci
$9.18
-2.0%
10/20/2026Reiterated RatingBuyView details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 10/20/2026
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
$125.10
-1.0%
10/20/2026Reiterated RatingBuyView details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 10/20/2026
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$13.16
+2.0%
10/20/2026Reiterated Rating$16.00BuyView details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 10/20/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$0.40
-5.5%
10/20/2026Reiterated RatingNeutralView details for HC Wainwright rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 10/20/2026
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$25.93
-2.3%
10/20/2026Reiterated Rating$66.00BuyView details for HC Wainwright rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/20/2026
Americas Gold and Silver Corporation stock logo
USAS
Americas Gold and Silver
$3.07
-3.8%
10/20/2026Reiterated Rating$9.25BuyView details for HC Wainwright rating of Americas Gold and Silver (NYSEAMERICAN:USAS) on 10/20/2026
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
$16.66
-2.3%
10/19/2026 Reiterated RatingBuyView details for HC Wainwright rating of Janux Therapeutics (NASDAQ:JANX) on 10/19/2026
Entrada Therapeutics, Inc. stock logo
TRDA
Entrada Therapeutics
$4.41
-6.8%
10/19/2026Reiterated RatingNeutralView details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 10/19/2026
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
$1.39
-64.8%
10/19/2026Lower Price Target$6.00 ➝ $4.00NeutralView details for HC Wainwright rating of Aardvark Therapeutics (NASDAQ:AARD) on 10/19/2026
Adagene Inc. Sponsored ADR stock logo
ADAG
Adagene
$2.41
-1.2%
10/19/2026Reiterated Rating$7.00BuyView details for HC Wainwright rating of Adagene (NASDAQ:ADAG) on 10/19/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
$21.96
-1.1%
10/19/2026Boost Price Target$55.00 ➝ $60.00BuyView details for HC Wainwright rating of Alto Neuroscience (NYSE:ANRO) on 10/19/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$11.25
-1.7%
10/19/2026Reiterated Rating$19.00BuyView details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 10/19/2026
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
$12.82
-2.4%
10/19/2026Reiterated Rating$36.00BuyView details for HC Wainwright rating of Crescent Biopharma (NASDAQ:CBIO) on 10/19/2026
Clene Inc. stock logo
CLNN
Clene
$3.88
10/19/2026Reiterated RatingBuyView details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 10/19/2026
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$61.23
-1.8%
10/19/2026Reiterated Rating$140.00BuyView details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 10/19/2026
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$41.52
-1.0%
10/19/2026Boost Price Target$65.00 ➝ $73.00BuyView details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 10/19/2026
HDRN
Hadron Energy
$0.75
+1.3%
10/19/2026Initiated CoverageBuyView details for HC Wainwright rating of Hadron Energy (NASDAQ:HDRN) on 10/19/2026
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
$48.13
-1.5%
10/19/2026Reiterated Rating$85.00BuyView details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 10/19/2026
Sol-Gel Technologies Ltd. stock logo
SLGL
Sol-Gel Technologies
$69.45
+3.1%
10/19/2026Reiterated Rating$110.00BuyView details for HC Wainwright rating of Sol-Gel Technologies (NASDAQ:SLGL) on 10/19/2026
Urogen Pharma stock logo
URGN
Urogen Pharma
$34.49
-1.9%
10/19/2026Reiterated Rating$75.00BuyView details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 10/19/2026
Uranium Royalty Corp. stock logo
UROY
Uranium Royalty
$3.43
+1.5%
10/19/2026Reiterated Rating$4.50BuyView details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 10/19/2026
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
$2.21
-8.3%
10/19/2026Reiterated Rating$10.00BuyView details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 10/19/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$417.97
-1.7%
10/16/2026 Set Price Target$500.00View details for HC Wainwright rating of UnitedHealth Group (NYSE:UNH) on 10/16/2026
enGene Holdings Inc. stock logo
ENGN
enGene
$1.56
-1.3%
10/16/2026Reiterated RatingBuyView details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 10/16/2026
$0. Later: $29.97. (Ad)

Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel

Download your free copy before the link expires today.
Humacyte, Inc. stock logo
HUMA
Humacyte
$0.44
+5.4%
10/16/2026Reiterated RatingBuyView details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 10/16/2026
Sutro Biopharma, Inc. stock logo
STRO
Sutro Biopharma
$9.33
-9.3%
10/16/2026Reiterated RatingBuyView details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 10/16/2026
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
$4.00
-3.1%
10/16/2026Reiterated Rating$10.00BuyView details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 10/16/2026
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$6.93
-7.0%
10/16/2026Reiterated RatingBuyView details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 10/16/2026
OPKO Health, Inc. stock logo
OPK
OPKO Health
$1.63
10/16/2026 Reiterated RatingBuyView details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 10/16/2026
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
$25.34
-0.7%
10/16/2026Boost Price Target$34.00 ➝ $36.00BuyView details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 10/16/2026
EIKN
Eikon Therapeutics
$7.26
-11.9%
10/16/2026Initiated Coverage$23.00BuyView details for HC Wainwright rating of Eikon Therapeutics (NASDAQ:EIKN) on 10/16/2026
EIKN
Eikon Therapeutics
$7.26
-11.9%
10/16/2026Initiated Coverage$23.00BuyView details for HC Wainwright rating of Eikon Therapeutics (NASDAQ:EIKN) on 10/16/2026
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
$15.47
-0.5%
10/15/2026Reiterated RatingBuyView details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 10/15/2026
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$58.02
-0.6%
10/15/2026Reiterated Rating$120.00BuyView details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 10/15/2026
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$24.05
-2.1%
10/15/2026Reiterated Rating$80.00BuyView details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 10/15/2026
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
$147.33
-2.0%
10/15/2026Reiterated Rating$245.00BuyView details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 10/15/2026
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$76.78
-2.2%
10/15/2026Reiterated Rating$158.00BuyView details for HC Wainwright rating of Dianthus Therapeutics (NASDAQ:DNTH) on 10/15/2026
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$8.22
-1.1%
10/15/2026Reiterated Rating$15.00BuyView details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 10/15/2026
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$311.50
-2.7%
10/15/2026Reiterated Rating$361.00BuyView details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 10/15/2026
Liquidia Corporation stock logo
LQDA
Liquidia
$42.65
+7.5%
10/15/2026Boost Price Target$58.00 ➝ $65.00BuyView details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 10/15/2026
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
$252.96
-2.3%
10/15/2026Reiterated Rating$1,201.00BuyView details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 10/15/2026
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$8.99
-1.1%
10/15/2026Initiated Coverage$14.00BuyView details for HC Wainwright rating of Sight Sciences (NASDAQ:SGHT) on 10/15/2026
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
$39.31
-1.7%
10/14/2026Reiterated RatingBuyView details for HC Wainwright rating of Edgewise Therapeutics (NASDAQ:EWTX) on 10/14/2026
Alector, Inc. stock logo
ALEC
Alector
$1.83
10/14/2026Boost Price Target$5.00 ➝ $8.00BuyView details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 10/14/2026
Biomea Fusion, Inc. stock logo
BMEA
Biomea Fusion
$0.60
+2.6%
10/14/2026Reiterated Rating$4.00BuyView details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 10/14/2026
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
$50.00
0.0%
10/14/2026Reiterated Rating$70.00BuyView details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 10/14/2026
Evotec AG stock logo
EVO
Evotec
$1.50
-2.6%
10/14/2026Reiterated Rating$4.00BuyView details for HC Wainwright rating of Evotec (NASDAQ:EVO) on 10/14/2026
Integra Resources Corp. stock logo
ITRG
Integra Resources
$2.21
-2.2%
10/14/2026Reiterated Rating$6.75BuyView details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 10/14/2026
Envoy Medical, Inc. stock logo
COCH
Envoy Medical
$0.60
-0.1%
10/13/2026Reiterated RatingBuyView details for HC Wainwright rating of Envoy Medical (NASDAQ:COCH) on 10/13/2026
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$12.36
+2.8%
10/13/2026Lower Price Target$19.00 ➝ $18.00BuyView details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 10/13/2026
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
$36.13
+0.3%
10/13/2026Reiterated Rating$55.00BuyView details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 10/13/2026
Incyte Corporation stock logo
INCY
Incyte
$115.71
-1.0%
10/13/2026Reiterated Rating$152.00BuyView details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 10/13/2026
Palisade Bio, Inc. stock logo
PALI
Palisade Bio
$1.33
-1.5%
10/13/2026Reiterated Rating$7.00BuyView details for HC Wainwright rating of Palisade Bio (NASDAQ:PALI) on 10/13/2026
Syndax Pharmaceuticals, Inc. stock logo
SNDX
Syndax Pharmaceuticals
$13.40
-1.3%
10/13/2026Reiterated Rating$38.00BuyView details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 10/13/2026
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$26.87
-4.8%
10/13/2026Reiterated Rating$44.00BuyView details for HC Wainwright rating of Zenas BioPharma (NASDAQ:ZBIO) on 10/13/2026
SailPoint, Inc. stock logo
SAIL
SailPoint
$21.79
+8.6%
10/12/2026 Reiterated RatingBuyView details for HC Wainwright rating of SailPoint (NASDAQ:SAIL) on 10/12/2026
Promis Neurosciences stock logo
PMN
Promis Neurosciences
$8.34
-7.1%
10/12/2026Reiterated RatingBuyView details for HC Wainwright rating of Promis Neurosciences (NASDAQ:PMN) on 10/12/2026
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$10.19
-3.3%
10/12/2026Reiterated RatingBuyView details for HC Wainwright rating of Climb Bio (NASDAQ:CLYM) on 10/12/2026
LB Pharmaceuticals Inc stock logo
LBRX
LB Pharmaceuticals
$38.73
-1.8%
10/12/2026Reiterated RatingBuyView details for HC Wainwright rating of LB Pharmaceuticals (NASDAQ:LBRX) on 10/12/2026
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
$89.27
-1.8%
10/12/2026Boost Price Target$105.00 ➝ $130.00BuyView details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 10/12/2026
Absci Corporation stock logo
ABSI
Absci
$9.18
-2.0%
10/12/2026Reiterated Rating$16.00BuyView details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 10/12/2026
American Bitcoin Corp. stock logo
ABTC
American Bitcoin
$7.51
-5.5%
10/12/2026Initiated Coverage$22.00BuyView details for HC Wainwright rating of American Bitcoin (NASDAQ:ABTC) on 10/12/2026
Compugen Ltd. stock logo
CGEN
Compugen
$1.94
-1.0%
10/12/2026Reiterated Rating$4.00BuyView details for HC Wainwright rating of Compugen (NASDAQ:CGEN) on 10/12/2026
Insmed, Inc. stock logo
INSM
Insmed
$93.39
-1.8%
10/12/2026Reiterated Rating$220.00BuyView details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 10/12/2026
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$87.63
+2.2%
10/12/2026Boost Price Target$96.00 ➝ $126.00BuyView details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 10/12/2026
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
$80.39
-3.3%
10/12/2026Boost Price Target$195.00 ➝ $200.00BuyView details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 10/12/2026
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
$20.55
-4.3%
10/12/2026Reiterated Rating$56.00BuyView details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 10/12/2026
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
$125.10
-1.0%
10/12/2026Lower Price Target$270.00 ➝ $246.00BuyView details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 10/12/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$7.35
+4.3%
10/12/2026Reiterated Rating$14.00BuyView details for HC Wainwright rating of SOPHiA GENETICS (NASDAQ:SOPH) on 10/12/2026
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$49.39
-1.2%
10/9/2026Reiterated RatingBuyView details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 10/9/2026
Gevo, Inc. stock logo
GEVO
Gevo
$1.16
+1.8%
10/9/2026 Reiterated RatingBuyView details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 10/9/2026
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
$1.40
+21.7%
10/9/2026Set Price Target$4.00View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 10/9/2026
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
$0.95
+4.2%
10/9/2026 Reiterated RatingBuyView details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 10/9/2026
Endeavour Silver Corporation stock logo
EXK
Endeavour Silver
$7.46
-2.5%
10/9/2026Reiterated Rating$17.00BuyView details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 10/9/2026
Elon Musk’s Hushed FCC Filing. Dec 8th. (Ad)

Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world. James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined. Few investors know this filing exists, but that is expected to change quickly.tc pixel

Click here to see details on Elon Musk's newest AI filing
First Majestic Silver Corp. stock logo
AG
First Majestic Silver
$14.76
-2.4%
10/9/2026Lower Price Target$27.00 ➝ $25.50BuyView details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 10/9/2026
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
$36.42
+0.2%
10/9/2026Downgrade$38.00 ➝ $36.50Buy ➝ HoldView details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 10/9/2026
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
$21.00
+9.4%
10/8/2026Lower Price Target$47.00 ➝ $27.00BuyView details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 10/8/2026
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
$0.77
+0.6%
10/8/2026Reiterated RatingBuyView details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 10/8/2026
Caribou Biosciences, Inc. stock logo
CRBU
Caribou Biosciences
$0.53
-4.9%
10/8/2026DowngradeBuy ➝ NeutralView details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 10/8/2026
Seaport Therapeutics, Inc. stock logo
SPTX
Seaport Therapeutics
$20.61
-0.7%
10/8/2026Reiterated Rating$50.00BuyView details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 10/8/2026
TOYO Co., Ltd. stock logo
TOYO
TOYO
$3.94
+2.1%
10/8/2026Reiterated Rating$18.00BuyView details for HC Wainwright rating of TOYO (NASDAQ:TOYO) on 10/8/2026
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
$1.40
-4.8%
10/7/2026Reiterated RatingBuyView details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 10/7/2026
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$125.63
+0.9%
10/7/2026Boost Price Target$115.00 ➝ $130.00BuyView details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 10/7/2026
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
$43.79
+9.5%
10/7/2026Boost Price Target$40.00 ➝ $50.00BuyView details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 10/7/2026

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms in the last 90 days. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

HC Wainwright's equity research team has issued ratings on 633 companies across 11 sectors over the past 12 months, covered by 27 analysts. The HC Wainwright analysts below are listed by number of ratings issued in the last year.

HC Wainwright Stock Coverage by Sector

HC Wainwright concentrates its research most heavily in Healthcare (73.0%), Technology (8.2%) and Materials (6.1%). The chart below shows how HC Wainwright's 638 rated companies are distributed across all 11 sectors it covers.

HC Wainwright - Frequently Asked Questions

HC Wainwright's analysts currently have buy-equivalent ratings on 601 companies. Recent upgrades to buy include Crescent Biopharma, Cardiff Oncology and Alumis.

HC Wainwright's highest-rated analysts by MarketBeat's accuracy score include Robert Burns, Matthew Caufield and Douglas Tsao. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 28 analysts at HC Wainwright.

HC Wainwright has the deepest coverage in Healthcare (73.0% of rated companies), Technology (8.2% of rated companies), Materials (6.1% of rated companies), Industrials (5.6% of rated companies) and Finance (2.2% of rated companies).

HC Wainwright issued 2,089 ratings over the last 12 months across 638 companies — an average of roughly 174 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current HC Wainwright analyst actions.